Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02630186
Brief Title: A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC

First Submitted : December 2, 2015
First Submitted that Met QC Criteria : December 10, 2015
First Posted : December 15, 2015 (Estimate)

Results First Submitted : November 1, 2018
Results First Submitted that Met QC Criteria : June 28, 2019
Results First Posted : July 4, 2019 (Estimate)

Last Update Submitted that Met QC Criteria : June 28, 2019
Last Update Posted : July 4, 2019 (Estimate)